Key result
Amiodarone successfully treated a neonate with refractory supraventricular tachycardia, though it should be reserved as a last resort due to significant side effects.
Why the study?
Does amiodarone successfully treat refractory supraventricular tachycardia in a neonate?
Does amiodarone successfully treat refractory supraventricular tachycardia in a neonate?
Amiodarone can be an effective last-resort treatment for refractory supraventricular tachycardia in neonates.
Answers are grounded in this paper and cite their sources.
May support last-resort amiodarone in refractory neonatal SVT; single case leaves efficacy and safety open for prospective study.
A 3-week-old neonate with supraventricular tachycardia unresponsive to traditional therapy was treated successfully with amiodarone. An electrophysiologic study suggested the presence of a concealed left-sided accessory atrioventricular pathway. Because of its significant side effects, amiodarone should be used only as a last resort in the treatment of neonatal supraventricular tachycardia.
No takes yet. Share an insight, caveat, or question.
ROSENBERG et al. (1988) studied this question. Amiodarone successfully treated a neonate with refractory supraventricular tachycardia, though it should be reserved as a last resort due to significant side effects.
Synapse has enriched 10 related papers. Consider them for comparative context: